AI-Powered blood test aims to spot colorectal cancer
NCT ID NCT06889844
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood test that uses artificial intelligence to find markers for colorectal cancer. Researchers want to see how often the test gives a false positive result in 250 people who have other cancers or gut diseases. Participants give one blood sample, and their medical records are checked for risk factors. The goal is to make colorectal cancer diagnosis easier and more accurate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
blood test
What this could lead to
If successful, this could lead to a simple, accurate blood test to help diagnose colorectal cancer earlier.
What could go wrong
This is an early observational study, not a treatment trial. The test may still have false positives or not work as well in larger, more diverse groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Centro Médico Asturias
RECRUITINGOviedo, Cantabria, Spain
-
Hospital Universitario HM Sanchinarro
RECRUITINGMadrid, Madrid, Spain
-
Hospital Universitario de Ourense
RECRUITINGOurense, Galicia, Spain
-
Hospitales HM de Malaga
RECRUITINGMálaga, Andalusia, Spain
-
MD Anderson Cancer Centre
ACTIVE_NOT_RECRUITINGMadrid, Madrid, Spain